FindTrial
Sign In

Real-time continuous blood glucose monitoring system and Intervention study in type 1 diabetes: a randomized controlled study (RCT)

The application of real-time continuous blood glucose monitoring in type 1 diabetes outpatient service management system

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009665
Enrollment
Unknown
Registered
2016-10-27
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

RT-CGMS group:RT-CGMS
Control group:Routine monitor system for blood glucos concentration

Sponsors

Liaocheng city people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of patients with T1DM at least in accordance with one of the following four conditions (1) significant metabolic disorder; (2) A tendency of DKA; (3) The islet autoantibody positive; (4) FC-P and 2hC-P =200pmol/L. 2. All needs to insulin treatment every day; 3. Long-term, illiquid residents living in this region medical center.

Exclusion criteria

Exclusion criteria: 1. Other types of diabetes; 2. Serious complications (Life expectancy is less than 1 year).

Design outcomes

Primary

MeasureTime frame
FPG;2hPG;HbA1c;The frequency of hypoglycaemia;The frequency of DKA;The incidence of diabetic retinopathy;UAER;The frequency of hospitalization;The total cost of treatment;—

Countries

China

Contacts

Public ContactShen Yanjun

Liaocheng City People's Hospital

18663560871@163.com+86 18663560871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026